Levetiracetam Intravenous Infusion as an Alternative to Oral Dosing in Patients with Partial‐Onset Seizures
Open Access
- 5 March 2007
- Vol. 48 (3), 589-592
- https://doi.org/10.1111/j.1528-1167.2006.00959.x
Abstract
Summary: Purpose: This multicenter, open‐label study evaluated the short‐term tolerability of intravenously (IV)‐infused levetiracetam (LEV; 500–1,500 mg/100 ml, 15 min, b.i.d.) as a substitute for the same oral dose. Methods: The study consisted of screening, 4‐day IV LEV and 1–7 days of follow‐up, and was conducted in 25 adults with partial‐onset seizures receiving adjunctive oral LEV. Results: During the 4‐day IV LEV, 11 (44%) subjects experienced at least one treatment‐emergent adverse event (TEAE), with headache and fatigue being the most frequently reported. Five (20%) subjects experienced TEAEs considered to be related to the study drug. The tolerability profile was consistent with that of oral LEV, with all events judged mild or moderate in severity, no discontinuations, and no serious AEs or deaths reported. No AE related to seizure worsening was reported during IV LEV or brief follow‐up. Conclusions: LEV IV appears to be a well‐tolerated, practical alternative in patients with partial‐onset seizures temporarily unable to take the drug orally.This publication has 10 references indexed in Scilit:
- Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic StudyEpilepsia, 2006
- Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizuresNeurology, 2006
- Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjectsClinical Therapeutics, 2006
- Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus—experience in 102 adult patientsSeizure, 2005
- Rapid Onset of Action of Levetiracetam in Refractory Epilepsy PatientsEpilepsia, 2005
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapyEpilepsy Research, 2003
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- Revisiting the Concept of Identifiable NeuronsBrain, Behavior and Evolution, 2000